Peripheral Vascular Catheters and Consoles: Top Brands per Segment in the U.S.

IVUS catheter Retrieved from: Boston Scientific

Throughout iData’s MedSKU analysis, six companies and over 30 brands were analyzed within six market segments including IVUS consoles, IVUS catheters, OCT consoles, OCT catheters, FFR consoles, and FFR catheters. Despite many market segments included in the MedSKU analysis, this blog focuses and dives deep into three specific segments:

  • Intravascular Ultrasound (IVUS) Catheters 
  • Fractional Flow Reserve (FFR) Guidewires
  • IVUS/FFR Consoles

iData’s recently completed MedSKU analysis includes an overview of the companies, products, and segments. In addition, iData’s analysis includes brand-level metrics such as revenue, units sold, unit share, revenue share, and average selling prices (ASPs). Based on the data, revenue and units sold both minimally decreased in Q2’ 20 as COVID-19 hit. Despite this, both revenue and units sold have begun climbing back up to pre-COVID levels and have exceeded historical numbers in Q2’ 21. 


(based on the number of units sold in the second quarter of 2021)

Fractional Flow Reserve (FFR) Guidewires

  1. Omniwire (Philips)
  2. Pressure Wire X (Abbott)

FFR is a guide wire-based procedure that can accurately measure blood pressure and flow through a specific part of the coronary artery. Philips has been able to increase its units sold for its Omniwire since the second quarter of 2021. In contrast, despite Abbott’s Pressure Wire X generating the second highest number of units sold in the FFR segment, the number has been decreasing and experiencing fluctuations since the beginning of the reporting period in 2018. Similarly, the revenue generated for Philips’s Omniwire has been exponentially increasing since Q2 ‘20. Although Abbott struggled to maintain a solid increase in units sold for its Pressure Wire X, the company generated more revenue in Q2 ‘21 than Q1 ‘21 with less units sold due to an increase in the product’s average selling price (ASP). 

Intravascular Ultrasound (IVUS) Catheters

  1. Eagle Eye Platinum (Philips)
  2. Visions PV .034 Rx (Philips)

Intravascular ultrasound (IVUS) can be used as an alternative or adjunctive imaging technique in peripheral procedures. IVUS provides the physician a cross-sectional image of the vessel. Overall, the IVUS market has been increasing since the first quarter of 2019. The IVUS pump market took some hits from COVID-19 in the second quarter of 2020, but the market recovered extremely quickly and continued to increase from Q3 ‘20 to Q2 ‘21. In terms of the most units sold, Philips’s Eagle Eye Platinum leads. However, despite being the leader in terms of units sold, the number of units sold in Q1 ‘21 was slightly higher than the number of units sold in Q2’ 21 indicating the start of a potential market decrease. 

Fractional Flow Reserve (FFR) Guidewires/Intravascular Ultrasound (IVUS) Consoles

  1. Insight 5 (Philips)
  2. Insight 7 (Philips)

Evidently, Philips dominates the IVUS and FFR consoles market. Philips states that the IntraSight platform allows physicians to perform intravascular ultrasound (IVUS) imaging and physiologic measurements of fractional flow reserve (FFR) and instant wave-free ratio (iFR) to accurately identify the location of lesions causing ischemia. As of recently, following the global COVID-19 pandemic and a decrease in Q2 ‘20, the IVUS/FFR console market has taken off. Philips Intrasight 5 performed the best in terms of overall units sold and revenue generated. However, the company’s Intrasight 7 was not very far behind, generating only $400K less in overall revenue, indicating close competition between these two brands. 


The MedSKU solution allows you to: quantify the impact of COVID-19 on the market, understand the market response to new product launches and determine the most popular product configurations (brands, dimensions, materials, etc.), and answer specific questions like:

– How has the market shifted in 2020 and 2021 following product recalls?

– Which catheter/console is the market shifting towards/away from the most? 

– How have certain products trended following changes in distribution?

– Has the market recovered from COVID-19? Are any competitors falling behind due to the pandemic?


View MedSKU in action 

Leave a Reply